Clinical Frequency and Characteristics of Peripheral Neuropathy in Dermatomyositis

Importance: The occurrence of peripheral neuropathy (PN) in dermatomyositis (DM) is poorly characterized. Objective: To characterize the occurrence, clinical patterns, and electrophysiological features of PN in patients with DM. Design, Setting, and Participants: This cohort study used data from a single academic center database of patients with DM who were enrolled between July 2008 and December 2025. Patients with PN were identified through medical record review of problem lists, encounter diagnoses, and clinical notes. PN diagnosis was established by clinical examination, nerve conduction study (NCS), or skin punch biopsy. Patients with PN that was associated with diabetes or prediabetes, vitamin deficiency, infection, trauma, nerve compression, radiculopathy, or neurotoxic medication were excluded. Exposures: DM subtype, autoantibody positivity, and systemic manifestations. Main Outcomes and Measures: Main outcomes were frequency and clinical/electrophysiological characteristics of PN among patients with DM. Results: Among 640 patients with DM (median [IQR] age, 60 [40.8-70.0] years; 546 [85.3%] female; 94 [14.7%] male), 120 (18.8%) had clinically documented PN (median [IQR] age, 60 [50.5-70.8] years; 104 [86.7%] female; 16 [13.3%] male), ascertained at a median (IQR) of 3 (1-9) years after DM diagnosis. Patients with PN were significantly more likely to have classic DM than patients without PN (75 of 120 [62.5%] vs 269 of 520 [51.7%]; P = .03). Patients with PN had higher rates of arthralgia (95 of 120 [79.2%] vs 93 of 511 [18.2%]; P < .001) and Raynaud syndrome (67 of 120 [55.8%] vs 198 of 511 [38.7%]; P < .001), and lower myositis-specific antibody positivity (28 of 104 patients [26.9%] vs 112 of 295 [38.0%]; P = .04), than patients without PN. NCS was performed in 61 patients, with positive findings in 39 patients (63.9%) and negative findings in 22 patients (36.1%). Mixed sensory-motor polyneuropathy was most common (23 of 39 patients [58.9%]), followed by pure sensory neuropathy (12 of 39 patients [30.8%]), with axonal features predominating (37 of 39 patients [94.9%]) over demyelinating features (2 of 39 patients [5.1%]). Small-fiber neuropathy was biopsy-confirmed in 4 patients (3.3%) and clinically suspected without biopsy confirmation in 16 patients (13.3%). Conclusions/Relevance: In this cohort study, clinically documented PN was identified in nearly one-fifth of the DM cohort after exclusion of secondary causes and was associated with classic DM subtype and higher rates of arthralgia and Raynaud syndrome. The predominance of axonal over demyelinating patterns on NCS suggests inflammatory axonal injury as one possible mechanism, though other causes cannot be excluded. These findings suggest PN is an underrecognized systemic association of DM warranting heightened clinical awareness and further mechanistic investigation.

Authors

Institutions

Publication Details

Journal
JAMA Dermatology
Published
2026-11-18
DOI
https://doi.org/10.1001/jamadermatol.2026.4739
Primary Topic
Inflammatory Myopathies and Dermatomyositis
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Clinical Frequency and Characteristics of Peripheral Neuropathy in Dermatomyositis

Laís Lopes Almeida Gomes, Sarini Saksena, Naomi Gross, Eric Lancaster et al.
JAMA Dermatology
Inflammatory Myopathies and Dermatomyositis
article

Clinical Frequency and Characteristics of Peripheral Neuropathy in Dermatomyositis

Laís Lopes Almeida Gomes, Sarini Saksena, Naomi Gross, Eric Lancaster, Victoria P. Werth, Rui Feng, Ahmed Eldaboush, Elena Wei, Sarah Jun
article en

Abstract

Importance: The occurrence of peripheral neuropathy (PN) in dermatomyositis (DM) is poorly characterized. Objective: To characterize the occurrence, clinical patterns, and electrophysiological features of PN in patients with DM. Design, Setting, and Participants: This cohort study used data from a single academic center database of patients with DM who were enrolled between July 2008 and December 2025. Patients with PN were identified through medical record review of problem lists, encounter diagnoses, and clinical notes. PN diagnosis was established by clinical examination, nerve conduction study (NCS), or skin punch biopsy. Patients with PN that was associated with diabetes or prediabetes, vitamin deficiency, infection, trauma, nerve compression, radiculopathy, or neurotoxic medication were excluded. Exposures: DM subtype, autoantibody positivity, and systemic manifestations. Main Outcomes and Measures: Main outcomes were frequency and clinical/electrophysiological characteristics of PN among patients with DM. Results: Among 640 patients with DM (median [IQR] age, 60 [40.8-70.0] years; 546 [85.3%] female; 94 [14.7%] male), 120 (18.8%) had clinically documented PN (median [IQR] age, 60 [50.5-70.8] years; 104 [86.7%] female; 16 [13.3%] male), ascertained at a median (IQR) of 3 (1-9) years after DM diagnosis. Patients with PN were significantly more likely to have classic DM than patients without PN (75 of 120 [62.5%] vs 269 of 520 [51.7%]; P = .03). Patients with PN had higher rates of arthralgia (95 of 120 [79.2%] vs 93 of 511 [18.2%]; P < .001) and Raynaud syndrome (67 of 120 [55.8%] vs 198 of 511 [38.7%]; P < .001), and lower myositis-specific antibody positivity (28 of 104 patients [26.9%] vs 112 of 295 [38.0%]; P = .04), than patients without PN. NCS was performed in 61 patients, with positive findings in 39 patients (63.9%) and negative findings in 22 patients (36.1%). Mixed sensory-motor polyneuropathy was most common (23 of 39 patients [58.9%]), followed by pure sensory neuropathy (12 of 39 patients [30.8%]), with axonal features predominating (37 of 39 patients [94.9%]) over demyelinating features (2 of 39 patients [5.1%]). Small-fiber neuropathy was biopsy-confirmed in 4 patients (3.3%) and clinically suspected without biopsy confirmation in 16 patients (13.3%). Conclusions/Relevance: In this cohort study, clinically documented PN was identified in nearly one-fifth of the DM cohort after exclusion of secondary causes and was associated with classic DM subtype and higher rates of arthralgia and Raynaud syndrome. The predominance of axonal over demyelinating patterns on NCS suggests inflammatory axonal injury as one possible mechanism, though other causes cannot be excluded. These findings suggest PN is an underrecognized systemic association of DM warranting heightened clinical awareness and further mechanistic investigation.

JAMA Dermatology
Philadelphia VA Medical Center (US), University of Pennsylvania (US)
Good health and well-being
Inflammatory Myopathies and Dermatomyositis
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon